CAPITAL STOCK (Tables)

12 Months Ended

Mar. 31, 2023

Equity [Abstract]

SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS

At March 31, 2023, 2022, and 2021 outstanding and exercisable stock purchase warrants consisted of the following:

	Number of Shares			Weighted Averaged Exercise Price		Weighted Average Life Remaining (Years)
Outstanding at March 31, 2020		8,504,372		$	2.10		3.60
Granted		2,925,204			2.31		2.47
Exercised		(7,821,631	)		2.08		-
Forfeited or cancelled		-			-		-
Outstanding at March 31, 2021		3,607,945		$	2.31		3.24
Exercisable at March 31, 2021		3,179,730		$	2.27		3.05

	Number of Shares			Weighted Averaged Exercise Price		Weighted Average Life Remaining (Years)
Outstanding at March 31, 2021		3,607,945		$	2.31		3.24
Granted		200,000			0.01		3.92
Exercised		(874,190	)		1.76		-
Forfeited or cancelled		-			-		-
Outstanding at March 31, 2022		2,933,755		$	2.32		2.29
Exercisable at March 31, 2022		2,933,755		$	2.32		2.29

	Number of Shares			Weighted Averaged Exercise Price		Weighted Average Life Remaining (Years)
Outstanding at March 31, 2022		2,933,755		$	2.32		2.29
Granted		150,000			0.01		4.5
Exercised		(300,003	)		0.34		-
Forfeited or cancelled		(322,806	)		2.00		-
Outstanding at March 31, 2023		2,460,946		$	2.46		1.59
Exercisable at March 31, 2023		2,460,946		$	2.46		1.59

As of March 31, 2023, we had 2,460,946 warrants outstanding. Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase 911 shares of Common Stock at an exercise price of $1.65 per share until April 2025; (2) warrants to purchase 1,448,758 shares of our Common Stock at an exercise price of $2.00 per share consisting of 16% of the warrants until August 2024, and 84% until February 2026; (3) warrants to purchase 474,966 shares of Common Stock at an exercise price of $2.40 until September 2024; (4) warrants to purchase 386,311 shares of Common Stock at an exercise price of $2.63 until November 2025, and (5) warrants to purchase 150,000 shares of Common Stock at an exercise price of $6.72 until February 2024.